Article content
Swift Medical unveils the new Skin & Wound 2 platform to heal our world faster with the power of AI.
TORONTO – Swift Medical, a pioneer in digital wound care, has launched the new Skin & Wound 2 platform. As the gold standard for the digital wound care segment it helped create, Swift’s award-winning platform has been used to screen more than 50 million patients in home health, the ambulatory, acute, and skilled nursing settings. With more than 22 peer-reviewed publications, the company has remained true to its commitment to clinically validate its innovation and have proven results with precision, AI equivalents and improved cure rates.
Article content
“Skin & Wound 2 demonstrates our continued commitment to empowering clinicians with the most advanced tools available, enabling the delivery of superior wound care outcomes,” said Dwayne Sansone, CEO of Swift Medical. “For nearly a decade, Swift Medical has been committed to delivering an inclusive, non-invasive approach to digital wound care. We see it as our moral responsibility to use the power of AI to revolutionize patient diagnosis, ensuring the most accurate results for every skin tone. Our mission is to Heal Our World Faster by using AI to ensure that every patient, regardless of background, receives the most accurate and equitable care possible.”
Skin & Wound 2 was developed with the advancement of the healthcare environment in mind and taking advantage of Swift’s patented AI technology. The new, state-of-the-art platform includes the latest FHIR standard, as well as best-in-class imaging and documentation on the market, tightly integrated with leading EMR platforms such as Homecare Homebase. It has a modern, seamless user interface that allows for accelerated analysis and a high level of submillimeter accuracy.
“Homecare Homebase has been a leader in integrating high-quality and reliable patient-centered technology. Our deep partnership with Swift provides our customers with the best digital wound care solution on the market to help patients heal faster,” said Scott Pattillo, Chief Strategy Officer.
In 2024, Swift passed a monthly wound care assessment by more than 21,000 doctors of all types. Swift’s dedication to growing the business without compromising quality has been the driving force behind the arrival of Skin & Wound 2. The new platform will allow for the rapid deployment of new features, including several additional groundbreaking capabilities planned for the next year.
About Swift Medical
Swift Medical is the market leader in digital healthcare with more than 4,800 healthcare facilities using its advanced AI-based solutions throughout the care continuum to improve prevention, treatment and management of wounds. Their proven ability to enable clinicians to deliver superior clinical outcomes has been published in over 22 peer-reviewed articles. To learn more about Swift’s research on equity in wound care and to read other publications, visit: https://swiftmedical.com/published-research/.
View the source version at businesswire.com: https://www.businesswire.com/news/home/20241020976878/en/
Contacts
Michelle Bohon
media@swiftmedical.com
#distro
Share this article on your social network
Source link